With only 5 more months left for this year to end, the FDA has already greenlighted 29 novel drugs so far. This figure stands in favorable contrast to last year's count of 16 novel approved drugs during the same time frame.Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before.